Carol Mangione

Type of Faculty: 
Part Time
Appointment Title: 
Professor
Address: 
10940 Wilshire Boulevard, Suite 700 Los Angeles, California 90024
310.794.2298
310.794.0723
Biographical Information: 

Carol M. Mangione, MD, MSPH, FACP, is the Barbara A. Levey, MD, and Gerald S. Levey, MD, endowed chair in medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and professor of public health at the UCLA Fielding School of Public Health. In addition, she serves as director of the UCLA/Drew Resource Center for Minority Aging Research/Center for Health Improvement of Minority Elderly, co-director of the UCLA Robert Wood Johnson Foundation Clinical Scholars Program, associate director of the UCLA Clinical and Translational Sciences (CTSI) and director of the UCLA CTSI Workforce Development Program. Dr. Mangione is also a practicing primary care physician in the UCLA Faculty Practice Group and a professor of medicine and public health at UCLA. She also serves as the national study co-chair for the multicenter program Natural Experiments in Translation for Diabetes, which is sponsored by the Centers for Disease Control and Prevention (CDC), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and Patient Centered Outcomes Research Institute (PCORI).

Dr. Mangione’s areas of expertise include diabetes, diabetes prevention, health disparities, aging, public health, health insurance benefit design, and public health policy. She is a member of numerous professional societies and organizations, including the American Society of Clinical Investigation, the Society for General Internal Medicine, the American Geriatrics Society, AcademyHealth, the American Diabetes Association, American College of Physicians and recently appointed to the U.S. Preventative Services Task Force. She was also a member of the Board of Governors for the Pardee RAND Graduate School.

Dr. Mangione was the principal investigator for “The Diabetes Health Plan: A System Level Intervention to Prevent and Treat Diabetes,” funded by the Centers for Disease Control (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to evaluate the effectiveness of the first disease specific health plan in the United States. This work focused on studying the influence of benefit design on prevention of diabetes, adherence to medications, and control of cardiovascular risk factors among persons with diabetes.  Dr. Mangione is the Principal Investigator of the “Managing Your Medication for Education and Daily Support,” (MYMEDS) program which embeds clinical pharmacists in primary care practices to enhance communication, educate, and improve medication adherence for patients with poor control of cardiovascular risk factors and in older adults who have polypharmacy and are struggling with adherence to their medications.  She is co-principal investigator of a grant from NIDDK, “A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the Diabetes Prevention Program,” which evaluates a primary care based program that uses a shared decision making tool to help patients with pre-diabetes learn about the condition and make treatment choices that will reduce their chance of developing diabetes.  Finally, she has recently received an award from CDC and NIDDK entitled “A Partnered Evaluation of United Health Care’s (UHC) Medicaid Plan Innovations for Diabetes Patients” that will evaluate health plan level innovations designed to improve the care of patients with chronic conditions in the Medicaid expansion population.  

Dr. Mangione was recognized in 2013 with the UCLA Exceptional Physician Award and in 2005 with the Society of General Internal Medicine Mid-Career Mentorship Award. She serves as a reviewer for the Journal of General Internal Medicine, New England Journal of Medicine, and the Journal of the American Medical Association. Dr. Mangione has authored more than 230 peer-reviewed articles and seven book chapters.

Dr. Mangione received her B.S. from the University of Michigan, Ann Arbor. She earned her M.D. at the University of California, San Francisco and completed her residency at University of California Affiliated Hospitals. Dr. Mangione earned her M.S.P.H. from the Harvard School of Public Health and has completed fellowships at Harvard Medical School.

Education: 
MSPH, Harvard School of Public Health
MD, University of California-San Francisco
BS, University of Michigan
Selected Publications: 
  • Frosch DL, Rincon D, Ochoa S, Mangione CM. Activating Seniors to Improve Chronic Disease Care: Results from a Pilot Intervention Study. J Am Geriatr Soc. 2010 Jul 19.
  • Bilik D, McEwen LN, Brown MB, Selby JV, Karter AJ, Marrero DG, Hsiao VC, Tseng CW, Mangione CM, Lasser NL, Crosson JC, Herman WH. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):715-21.
  • Baig AA, Mangione CM, Sorrell-Thompson AL, Miranda JM. A randomized community-based intervention trial comparing faith community nurse referrals to telephone-assisted physician appointments for health fair participants with elevated blood pressure. J Gen Intern Med. 2010 Jul;25(7):701-9.
  • Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter? J Gen Intern Med. 2010 Jun 23.
  • Schmittdiel JA, Steers N, Duru OK, Ettner SL, Brown AF, Fung V, Hsu J, Quiter E, Tseng CW, Mangione CM. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study. BMC Health Serv Res. 2010 Jun 14;10:164.
  • Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. The predictors of patient-physician race and ethnic concordance: a medical facility fixed-effects approach. Health Serv Res. 2010 Jun;45(3):792-805.
  • Ettner SL, Steers N, Duru OK, Turk N, Quiter E, Schmittdiel J, Mangione CM. Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics. J Gen Intern Med. 2010 Jun;25(6):568-74.
  • Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng CW. Generic-Only Drug Coverage in the Medicare Part D Gap and Effect on Medication Cost-Cutting Behaviors for Patients with Diabetes Mellitus: The Translating Research into Action for Diabetes Study. J Am Geriatr Soc. 2010 Apr 6.
  • Smith AL, Wang PC, Anger JT, Mangione CM, Trejo L, Rodríguez LV, Sarkisian CA. Correlates of Urinary Incontinence in Community-Dwelling Older Latinos. J Am Geriatr Soc. 2010 Apr 6.
  • Tseng CW, Brook RH, Alexander GC, Hixon AL, Keeler EB, Mangione CM, Chen R, Jackson EA, Dudley RA. Health information technology and physicians' knowledge of drug costs. Am J Manag Care. 2010 Apr 1;16(4):e105-10.
  • Kodjebacheva G, Coleman AL, Ensrud KE, Cauley JA, Yu F, Stone KL, Pedula KL, Hochberg MC, Mangione CM. Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures. Am J Ophthalmol. 2010 Feb;149(2):330-40.          
  • Diabetes
  • Health Disparities
  • Public Health
  • Public Health Policy

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer